ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Clinuvel Pharmaceuticals Ltd.
5.87
-0.0800
-1.34%
盤後：
5.87
0.0000
0.00%
19:30 EDT
成交量：
1.39萬
成交額：
8.21萬
市值：
2.96億
市盈率：
12.70
高：
6.00
開：
5.81
低：
5.81
收：
5.95
52周最高：
8.92
52周最低：
5.80
股本：
5,042.79萬
流通股本：
4,387.83萬
量比：
0.37
換手率：
0.03%
股息：
0.04
股息率：
0.61%
每股收益(TTM):
0.4621
每股收益(LYR):
0.4621
淨資產收益率：
13.21%
總資產收益率：
8.94%
市淨率：
1.52
市盈率(LYR):
12.70
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Clinuvel Pharmaceuticals Ltd.
交易所：
NASDAQ
成立時間：
1999
員工人數：
16
公司地址：
535 Bourke Street,Level 22,Melbourne,Victoria,Australia
官網：
http://www.clinuvel.com
郵編：
3000
電話：
61 3 9660 4900
傳真：
61 3 9660 4999
簡介：
Clinuvel Pharmaceuticals Limited是一家於1999年根據澳大利亞法律註冊成立的股份有限公司。該公司是一家全球性專業製藥集團，專註於為患有遺傳性、代謝性、全身性和危及生命的急性疾病的患者開發治療方法並將其商業化，以及為專門人群開發醫療保健解決方案，業務遍及歐洲、新加坡和美國。
董事
名稱
職位
Guy van Dievoet
Non-Executive Director
Jeffrey Rosenfeld
Chair of the Board and Non-Executive Director
Karen Agersborg
Non-Executive Director
Matthew Pringle
Non-Executive Director
Pearl Grimes
Non-Executive Director
Susan Smith
Non-Executive Director
股東
名稱
職位
Philippe Wolgen
Chief Executive Officer and Managing Director
Lachlan Hay
Chief Operating Officer
Peter Vaughan
Chief Financial Officer
Dennis Wright
Chief Scientific Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/CUVL/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CUVL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUVL\",,,,,undefined,":{"symbol":"CUVL","market":"US","secType":"STK","nameCN":"Clinuvel Pharmaceuticals Ltd.","latestPrice":5.87,"timestamp":1789416000000,"preClose":5.95,"halted":0,"volume":13881,"hourTrading":{"tag":"盘后","latestPrice":5.87,"preClose":5.87,"latestTime":"19:30 EDT","volume":3,"amount":17.61,"timestamp":1789428601806,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.013445378151260515,"floatShares":43878300,"shares":50427898,"eps":0.462123,"marketStatus":"未開盤","change":-0.08,"latestTime":"09-14 16:00:00 EDT","open":5.81,"high":6,"low":5.81,"amount":82138.999089,"amplitude":0.031933,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.462123,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"adrRate":1,"exchange":"NASDAQ","adjPreClose":5.95,"dividendRate":0.006104,"postHourTrading":{"tag":"盘后","latestPrice":5.87,"preClose":5.87,"latestTime":"19:30 EDT","volume":3,"amount":17.61,"timestamp":1789428601806,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.36731},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUVL\",,,,,undefined,":{"symbol":"CUVL","floatShares":43878300,"roa":"8.94%","roe":"13.21%","lyrEps":0.462123,"volumeRatio":0.36731,"shares":50427898,"dividePrice":0.035597,"high":6,"amplitude":0.031933,"preClose":5.95,"low":5.81,"week52Low":5.8,"pbRate":"1.52","psRate":"4.42","week52High":8.92,"institutionHeld":0,"latestPrice":5.87,"eps":0.462123,"divideRate":0.006064,"volume":13881,"delay":0,"ttmEps":0.462123,"open":5.81,"prevYearClose":8.48,"prevWeekClose":5.95,"prevMonthClose":5.95,"prevQuarterClose":7.3,"fiveDayClose":6.52,"twentyDayClose":6.9,"sixtyDayClose":7.36,"dividendPayoutRate":0.055654438728341596,"dividendFrequency":"A","dividendGrowthYears":0,"dividendGrowthRate":-0.12779744805932258,"fiveYearAvgDividendRate":0.004014656862745098},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUVL\",params:#limit:5,,,undefined,":[{"date":"2026-09-08","symbol":"CUVL","amount":0.03582,"announcedDate":"2026-08-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-08","defaultRemindTime":1788874200000,"name":"Clinuvel Pharmaceuticals Ltd.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-28","payableDate":"2026-09-08","currency":"USD","dateTimestamp":1788840000000,"payDate":"2026-09-28"},{"date":"2026-08-27","symbol":"CUVL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787817600000,"name":null,"time":"盤前","dateTimestamp":1787803200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUVL\",market:\"US\",,,undefined,":[{"executeDate":"2026-09-08","recordDate":"2026-09-08","paymentDate":"2026-09-28","value":0.03582,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CUVL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.2857,"hold":0.4286,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2857,"analysts":7,"updateTime":1787889600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CUVL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CUVL","date":"2026-09-11","current":12.702246,"percent":0.054054,"low":11.909356,"twenty":12.340531,"median":14.761136,"eighty":15.75761,"high":16.876512,"avg":14.404698,"sd":1.501382,"marketCap":290763266.64},"quantilePoints":[{"date":"2026-07-24","current":15.59024,"twenty":15.398074,"median":15.574742,"eighty":15.64603,"marketCap":353645627.74},{"date":"2026-07-31","current":14.040514,"twenty":14.675902,"median":15.311289,"eighty":15.580941,"marketCap":320255681.34},{"date":"2026-08-07","current":14.62941,"twenty":14.316365,"median":14.745639,"eighty":15.481759,"marketCap":334861674.87},{"date":"2026-08-14","current":14.79988,"twenty":14.434144,"median":14.861869,"eighty":15.354681,"marketCap":340007360.21},{"date":"2026-08-21","current":16.148141,"twenty":14.496133,"median":14.978098,"eighty":15.70182,"marketCap":374125095.76},{"date":"2026-08-28","current":12.593289,"twenty":14.434144,"median":15.047836,"eighty":16.017964,"marketCap":307239459.07},{"date":"2026-09-04","current":12.117509,"twenty":14.049812,"median":14.861869,"eighty":15.918781,"marketCap":295738193.85},{"date":"2026-09-11","current":11.95396,"twenty":12.340531,"median":14.761136,"eighty":15.75761,"marketCap":290763266.64}],"updateTime":1789447184655},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4999","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":-0.0874},{"period":"1month","weight":-0.1093},{"period":"3month","weight":-0.049},{"period":"6month","weight":-0.1849},{"period":"1year","weight":-0.1736},{"period":"ytd","weight":-0.2983}],"compareEarnings":[{"period":"1week","weight":-0.0121},{"period":"1month","weight":-0.0199},{"period":"3month","weight":0.0141},{"period":"6month","weight":0.1504},{"period":"1year","weight":0.1574},{"period":"ytd","weight":0.1158}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Clinuvel Pharmaceuticals Limited是一家於1999年根據澳大利亞法律註冊成立的股份有限公司。該公司是一家全球性專業製藥集團，專註於為患有遺傳性、代謝性、全身性和危及生命的急性疾病的患者開發治療方法並將其商業化，以及為專門人群開發醫療保健解決方案，業務遍及歐洲、新加坡和美國。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.016564},{"month":2,"riseRate":0.25,"avgChangeRate":-0.088904},{"month":3,"riseRate":0.375,"avgChangeRate":0.036975},{"month":4,"riseRate":0.625,"avgChangeRate":0.007121},{"month":5,"riseRate":0.555556,"avgChangeRate":0.057074},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.013615},{"month":7,"riseRate":0.555556,"avgChangeRate":0.025547},{"month":8,"riseRate":0.555556,"avgChangeRate":0.019073},{"month":9,"riseRate":0.444444,"avgChangeRate":0.030613},{"month":10,"riseRate":0.5,"avgChangeRate":-0.018995},{"month":11,"riseRate":0.5,"avgChangeRate":-0.022089},{"month":12,"riseRate":0.625,"avgChangeRate":0.039793}],"exchange":"NASDAQ","name":"Clinuvel Pharmaceuticals Ltd.","nameEN":"Clinuvel Pharmaceuticals Ltd.","securityTypeName":"存托凭证","adrRate":"1:1"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CUVL\",market:\"US\",,,undefined,":{"directors":[{"name":"Guy van Dievoet","position":"Non-Executive Director"},{"name":"Jeffrey Rosenfeld","position":"Chair of the Board and Non-Executive Director"},{"name":"Karen Agersborg","position":"Non-Executive Director"},{"name":"Matthew Pringle","position":"Non-Executive Director"},{"name":"Pearl Grimes","position":"Non-Executive Director"},{"name":"Susan Smith","position":"Non-Executive Director"}],"executives":[{"name":"Philippe Wolgen","position":"Chief Executive Officer and Managing Director"},{"name":"Lachlan Hay","position":"Chief Operating Officer"},{"name":"Peter Vaughan","position":"Chief Financial Officer"},{"name":"Dennis Wright","position":"Chief Scientific Officer"}]}}}